PCB-induced endothelial cell dysfunction: Role of poly(ADP-ribose) polymerase

Biochemical Pharmacology

Volumn 78, Issue 8, 2009, Pages 959-965

  Helyar, Simon G ^a   Patel, Bella ^b   Headington, Kevin ^b   El Assal, Mary ^b   Chatterjee, Prabal K ^b   Pacher, Pal ^c   Mabley, Jon G ^b  

^a BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF BRIGHTON   (United Kingdom)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Atherosclerosis; Cardiovascular; Oxidative stress; PARP; Polychlorinated biphenyl

Indexed keywords

ACETYLCHOLINE; CYTOCHROME P450 1A1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; POLYCHLORINATED BIPHENYL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME INHIBITION; EX VIVO STUDY; IN VITRO STUDY; LONG TERM EXPOSURE; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEPLETION; RAT; VASCULAR ENDOTHELIUM; VASCULAR RING; VASODILATATION;

ACETYLCHOLINE; ANIMALS; AORTA, THORACIC; CELL SURVIVAL; CELLS, CULTURED; CYTOCHROME P-450 CYP1A1; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; ENVIRONMENTAL POLLUTANTS; INDICATORS AND REAGENTS; MALE; MICE; MOLECULAR STRUCTURE; MUSCLE, SMOOTH, VASCULAR; NADP; NITRIC OXIDE; NITROBLUE TETRAZOLIUM; OXIDANTS; OXIDATION-REDUCTION; OXIDATIVE STRESS; POLY(ADP-RIBOSE) POLYMERASES; POLYCHLORINATED BIPHENYLS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; VASODILATION;

EID: 69349089451     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2009.06.019     Document Type: Article

References (51)

1. Carpenter D.O. Polychlorinated biphenyls (PCBs): routes of exposure and effects on human health. Rev Environ Health 21 1 (2006) 1-23
2. Turrio-Baldassarri L., Abate V., Alivernini S., Battistelli C.L., Carasi S., Casella M., et al. A study on PCB, PCDD/PCDF industrial contamination in a mixed urban-agricultural area significantly affecting the food chain and the human exposure. Part I. Soil and feed. Chemosphere 67 9 (2007) 1822-1830
3. Warner M., Eskenazi B., Patterson D.G., Clark G., Turner W.E., Bonsignore L., et al. Dioxin-like TEQ of women from the Seveso, Italy area by ID-HRGC/HRMS and CALUX. J Expo Anal Environ Epidemiol 15 4 (2005) 310-318
4. Hennig B., Reiterer G., Majkova Z., Oesterling E., Meerarani P., and Toborek M. Modification of environmental toxicity by nutrients: implications in atherosclerosis. Cardiovasc Toxicol 5 2 (2005) 153-160
5. Hennig B., Meerarani P., Slim R., Toborek M., Daugherty A., Silverstone A.E., et al. Proinflammatory properties of coplanar PCBs: in vitro and in vivo evidence. Toxicol Appl Pharmacol 181 3 (2002) 174-183
6. Toborek M., Barger S.W., Mattson M.P., Espandiari P., Robertson L.W., and Hennig B. Exposure to polychlorinated biphenyls causes endothelial cell dysfunction. J Biochem Toxicol 10 4 (1995) 219-226
7. Slim R., Toborek M., Robertson L.W., and Hennig B. Antioxidant protection against PCB-mediated endothelial cell activation. Toxicol Sci 52 2 (1999) 232-239
8. Lim E.J., Majkova Z., Xu S., Bachas L., Arzuaga X., Smart E., et al. Coplanar polychlorinated biphenyl-induced CYP1A1 is regulated through caveolae signaling in vascular endothelial cells. Chem Biol Interact 176 2-3 (2008) 71-78
9. Slim R., Toborek M., Robertson L.W., Lehmler H.J., and Hennig B. Cellular glutathione status modulates polychlorinated biphenyl-induced stress response and apoptosis in vascular endothelial cells. Toxicol Appl Pharmacol 166 1 (2000) 36-42
10. Eum S.Y., Rha G.B., Hennig B., and Toborek M. c-Src is the primary signaling mediator of polychlorinated biphenyl-induced interleukin-8 expression in a human microvascular endothelial cell line. Toxicol Sci 92 1 (2006) 311-320
11. Eum S.Y., Andras I.E., Couraud P.O., Hennig B., and Toborek M. Pcbs and tight junction expression. Environ Toxicol Pharmacol 25 2 (2008) 234-240
12. Lee Y.W., Park H.J., Son K.W., Hennig B., Robertson L.W., and Toborek M. 2,2′,4,6,6′-Pentachlorobiphenyl (PCB 104) induces apoptosis of human microvascular endothelial cells through the caspase-dependent activation of CREB. Toxicol Appl Pharmacol 189 1 (2003) 1-10
13. Choi W., Eum S.Y., Lee Y.W., Hennig B., Robertson L.W., and Toborek M. PCB 104-induced proinflammatory reactions in human vascular endothelial cells: relationship to cancer metastasis and atherogenesis. Toxicol Sci 75 1 (2003) 17-56
14. Kreiss K., Zack M.M., Kimbrough R.D., Needham L.L., Smrek A.L., and Jones B.T. Association of blood pressure and polychlorinated biphenyl levels. J Am Med Assoc 245 24 (1981) 2505-2509
15. Lee D.H., Lee I.K., Porta M., Steffes M., and Jacobs Jr. D.R. Relationship between serum concentrations of persistent organic pollutants and the prevalence of metabolic syndrome among non-diabetic adults: results from the National Health and Nutrition Examination Survey 1999-2002. Diabetologia 50 9 (2007) 1841-1851
16. Everett C.J., Mainous III A.G., Frithsen I.L., Player M.S., and Matheson E.M. Association of polychlorinated biphenyls with hypertension in the 1999-2002 National Health and Nutrition Examination Survey. Environ Res 108 1 (2008) 94-97
17. Garcia Soriano F., Virag L., Jagtap P., Szabo E., Mabley J.G., Liaudet L., et al. Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation. Nat Med 7 1 (2001) 108-113
18. Soriano F.G., Pacher P., Mabley J., Liaudet L., and Szabo C. Rapid reversal of the diabetic endothelial dysfunction by pharmacological inhibition of poly(ADP-ribose) polymerase. Circ Res 89 8 (2001) 684-691
19. Pacher P., Mabley J.G., Soriano F.G., Liaudet L., and Szabo C. Activation of poly(ADP-ribose) polymerase contributes to the endothelial dysfunction associated with hypertension and aging. Int J Mol Med 9 6 (2002) 659-664
20. Pacher P., Mabley J.G., Soriano F.G., Liaudet L., Komjati K., and Szabo C. Endothelial dysfunction in aging animals: the role of poly(ADP-ribose) polymerase activation. Br J Pharmacol 135 6 (2002) 1347-1350
21. Pacher P., Liaudet L., Bai P., Virag L., Mabley J.G., Hasko G., et al. Activation of poly(ADP-ribose) polymerase contributes to development of doxorubicin-induced heart failure. J Pharmacol Exp Ther 300 3 (2002) 862-867
22. Soriano F.G., Liaudet L., Szabo E., Virag L., Mabley J.G., Pacher P., et al. Resistance to acute septic peritonitis in poly(ADP-ribose) polymerase-1-deficient mice. Shock 17 4 (2002) 286-292
23. Samai M., Hague T., Naughton D.P., Gard P.R., and Chatterjee P.K. Reduction of paraquat-induced renal cytotoxicity by manganese and copper complexes of EGTA and EHPG. Free Radic Biol Med 44 4 (2008) 711-721
24. Lai K.P., Wong M.H., and Wong C.K. Modulation of AhR-mediated CYP1A1 mRNA and EROD activities by 17beta-estradiol and dexamethasone in TCDD-induced H411E cells. Toxicol Sci 78 1 (2004) 41-49
25. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
26. Mabley J.G., Suarez-Pinzon W.L., Hasko G., Salzman A.L., Rabinovitch A., Kun E., et al. Inhibition of poly (ADP-ribose) synthetase by gene disruption or inhibition with 5-iodo-6-amino-1,2-benzopyrone protects mice from multiple-low-dose-streptozotocin-induced diabetes. Br J Pharmacol 133 6 (2001) 909-919
27. Nakamura J., Asakura S., Hester S.D., de Murcia G., Caldecott K.W., and Swenberg J.A. Quantitation of intracellular NAD (P)H can monitor an imbalance of DNA single strand break repair in base excision repair deficient cells in real time. Nucleic Acids Res 31 17 (2003) e104
28. Bachmann K., Sanyal G., Potter J., Schiavone R., and Loch J. In vivo evidence that theophylline is metabolized principally by CYP1A in rats. Pharmacology 47 1 (1993) 1-7
29. Jagtap P., Soriano F.G., Virag L., Liaudet L., Mabley J., Szabo E., et al. Novel phenanthridinone inhibitors of poly (adenosine 5′-diphosphate-ribose) synthetase: potent cytoprotective and antishock agents. Crit Care Med 30 5 (2002) 1071-1082
30. Jensen A.A. Background levels in humans. In: Kimbrough R.D., and Jensen A.A. (Eds). Halogenated biphenyls, terphenyls, naphthalenes, dibenzodioxins and related products (1989), Elsevier Science Publishers 345-364
31. Wassermann M., Wassermann D., Cucos S., and Miller H.J. World PCBs map: storage and effects in man and his biologic environment in the 1970s. Ann N Y Acad Sci 320 (1979) 69-124
32. Lotti M. Pharmacokinetics and blood levels of polychlorinated biphenyls. Toxicol Rev 22 4 (2003) 203-215
33. Lin C.H., and Lin P.H. Induction of ROS formation, poly (ADP-ribose) polymerase-1 activation, and cell death by PCB126 and PCB153 in human T47D and MDA-MB-231 breast cancer cells. Chem Biol Interact (2006)
34. Szabo C., and Dawson V.L. Role of poly (ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. Trends Pharmacol Sci 19 7 (1998) 287-298
35. Pacher P., Beckman J.S., and Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87 1 (2007) 315-424
36. Walsh T., Donnelly T., and Lyons D. Impaired endothelial nitric oxide bioavailability: a common link between aging, hypertension, and atherogenesis?. J Am Geriatr Soc 57 1 (2009) 140-145
37. Yaghoubi M., Oliver-Krasinski J., Cayatte A.J., and Cohen R.A. Decreased sensitivity to nitric oxide in the aorta of severely hypercholesterolemic apolipoprotein E-deficient mice. J Cardiovasc Pharmacol 36 6 (2000) 751-757
38. Ding H., Hashem M., Wiehler W.B., Lau W., Martin J., Reid J., et al. Endothelial dysfunction in the streptozotocin-induced diabetic apoE-deficient mouse. Br J Pharmacol 146 8 (2005) 1110-1118
39. Benko R., Pacher P., Vaslin A., Kollai M., and Szabo C. Restoration of the endothelial function in the aortic rings of apolipoprotein E deficient mice by pharmacological inhibition of the nuclear enzyme poly (ADP-ribose) polymerase. Life Sci 75 10 (2004) 1255-1261
40. Hans C.P., Zerfaoui M., Naura A.S., Catling A., and Boulares A.H. Differential effects of PARP inhibition on vascular cell survival and ACAT-1 expression favouring atherosclerotic plaque stability. Cardiovasc Res 78 3 (2008) 429-439
41. Pacher P., and Szabo C. Role of the peroxynitrite-poly (ADP-ribose) polymerase pathway in human disease. Am J Pathol 173 1 (2008) 2-13
42. Oumouna-Benachour K., Hans C.P., Suzuki Y., Naura A., Datta R., Belmadani S., et al. Poly (ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death. Circulation 115 18 (2007) 2442-2450
43. Hans C.P., Zerfaoui M., Naura A., Troxclair D., Strong J.P., Matrougui K., et al. Thieno[2,3-c]isoquinolin-5-one (TIQ-A), a potent poly (ADP-ribose) polymerase inhibitor, promotes atherosclerotic plaque regression in high fat diet-fed ApoE-deficient mice: effects on inflammatory markers and lipid content. J Pharmacol Exp Ther (2009)
44. Toborek M., Lee Y.W., Garrido R., Kaiser S., and Hennig B. Unsaturated fatty acids selectively induce an inflammatory environment in human endothelial cells. Am J Clin Nutr 75 1 (2002) 119-125
45. Oliver F.J., M-dM J., Nacci C., Decker P., Andriantsitohaina R., Muller S., et al. Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice. EMBO J 18 16 (1999) 4446-4454
46. Andreone T.L., O'Connor M., Denenberg A., Hake P.W., and Zingarelli B. Poly (ADP-ribose) polymerase-1 regulates activation of activator protein-1 in murine fibroblasts. J Immunol 170 4 (2003) 2113-2120
47. Hasko G., Mabley J.G., Nemeth Z.H., Pacher P., Deitch E.A., and Szabo C. Poly (ADP-ribose) polymerase is a regulator of chemokine production: relevance for the pathogenesis of shock and inflammation. Mol Med 8 5 (2002) 283-289
48. Piconi L., Quagliaro L., Da Ros R., Assaloni R., Giugliano D., Esposito K., et al. Intermittent high glucose enhances ICAM-1, VCAM-1, E-selectin and interleukin-6 expression in human umbilical endothelial cells in culture: the role of poly (ADP-ribose) polymerase. J Thromb Haemost 2 8 (2004) 1453-1459
49. von Lukowicz T., Hassa P.O., Lohmann C., Boren J., Braunersreuther V., Mach F., et al. PARP1 is required for adhesion molecule expression in atherogenesis. Cardiovasc Res 78 1 (2008) 158-166
50. Giddings J.C. Soluble adhesion molecules in inflammatory and vascular diseases. Biochem Soc Trans 33 Pt 2 (2005) 406-408
51. Lenzser G., Kis B., Snipes J.A., Gaspar T., Sandor P., Komjati K., et al. Contribution of poly (ADP-ribose) polymerase to postischemic blood-brain barrier damage in rats. J Cereb Blood Flow Metab 27 7 (2007) 1318-1326